| Name | Title | Contact Details |
|---|
Hopscotch Press is a Berkeley, CA-based company in the Consumer Services sector.
EYEMG is one of the leading companies in the Consumer Services sector.
Goettl Air Conditioning is an HVAC services company offering exceptional air conditioning and heating services throughout the Phoenix, Tucson, Las Vegas, and Southern California areas. Established in 1939, Goettl offers the highest quality AC and heating equipment and a full range of maintenance, repair and replacement services. Goettl is a company devoted to each of their customers, with a focus on providing the best in home environmental solutions, from matching customers homes with the right sized and cost air conditioner to recommending the perfect air cleaner and humidifier combinations, Goettl strives for homes to be as safe and comfortable as possible. Goettl ensures customers can relax with the peace of mind knowing their home will remain comfortable in all conditions. From a well maintained heating system to an efficient duct system and indoor air quality system, to a properly sealed attic that blocks excess heat from entering your home. Through it`s sister company, The Sunny Plumber, Goettl also provides customers with plumbing and drain services.
Summit Environmental Corporation Inc is a Longview, TX-based company in the Consumer Services sector.
Flamel Technologies SA is a specialty pharmaceutical company utilizing its core competencies in formulation development and drug delivery to develop safer and more efficacious pharmaceutical products, addressing unmet medical needs and/or reducing overall healthcare costs. Flamel currently has approvals for and markets two previously Unapproved Marketed Drugs ("UMDs") in the USA, Bloxiverz® (neostigmine methylsulfate injection) and Vazculep® (phenylephrine hydrochloride injection). The Company intends to add to this branded business by creating additional products, focusing on the development of products utilizing Flamel`s proprietary drug delivery platforms, and recently announced FDA acceptance of its third NDA filing with an FDA-assigned PDUFA date of April 30, 2016. Flamel also has several products in development utilizing Micropump® (oral sustained release microparticles platform) along with its tangent technologies, LiquiTime® and Trigger Lock™. The lead project for Micropump® is sodium oxybate. LiquiTime® allows for the extended-release of liquid medicines (such as ibuprofen and guaifenesin) and Trigger Lock™ is an abuse-resistant iteration of Micropump®, designed specifically for long-acting opioids (such as hydromorphone). Additionally, the Company has developed a long acting injectable platform, Medusa™, a hydrogel depot technology currently being studied with exenatide. Flamel`s products are targeting high-value molecules and will utilize either the 505(b)(2) approval process for NDAs or biosimilar pathways ultimately approved by FDA and other regulatory authorities. The Company is headquartered in Lyon, France and has operations in St. Louis, Missouri, USA, and Dublin, Ireland.